| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vera Therapeutics, Inc. | Director | Class A Common Stock | 2.96M | $53.3M | $18.00 | May 18, 2021 | Indirect |
| Vera Therapeutics, Inc. | Director | Class A Common Stock | 17.8K | $321K | $18.00 | May 17, 2021 | Direct |
| CymaBay Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.94 | Mar 22, 2024 | Direct |
| Vaxcyte, Inc. | Director | Stock option (right to buy) | 15K | Jun 2, 2021 | Direct | ||
| Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 9.93K | May 13, 2021 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.5K | Jun 6, 2024 | Direct | ||
| CymaBay Therapeutics, Inc. | Director | Stock Appreciation Right | 0 | Sep 29, 2023 | Direct | ||
| CymaBay Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | Mar 22, 2024 | Direct | ||
| Vera Therapeutics, Inc. | Director | Series C Preferred Stock | 0 | May 18, 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| CBAY | CymaBay Therapeutics, Inc. | Mar 22, 2024 | 13 | $0 | 4 | Mar 22, 2024 | Director |
| CBAY | CymaBay Therapeutics, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Director |
| CBAY | CymaBay Therapeutics, Inc. | Sep 29, 2023 | 6 | -$170K | 4 | Sep 29, 2023 | Director |
| JSPR | Jasper Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| JSPR | Jasper Therapeutics, Inc. | Apr 13, 2023 | 1 | -$13.5K | 4 | Apr 14, 2023 | Director |
| CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | Director |
| JSPR | Jasper Therapeutics, Inc. | Oct 12, 2022 | 1 | $0 | 4 | Oct 13, 2022 | Director |
| JSPR | Jasper Therapeutics, Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Director, 10%+ Owner |
| CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | Director |
| JSPR | Jasper Therapeutics, Inc. | Sep 24, 2021 | 0 | $0 | 3 | Oct 1, 2021 | Director, 10%+ Owner |
| PCVX | Vaxcyte, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |
| VERA | Vera Therapeutics, Inc. | May 17, 2021 | 4 | $8.71M | 4 | May 18, 2021 | Director |
| VERA | Vera Therapeutics, Inc. | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director, 10%+ Owner |
| VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director, 10%+ Owner |